Home › Funds › Catalio Capital Management, LP › ARWR
Catalio Capital Management, LP position in ARWR
ARROWHEAD PHARMACEUTICALS IN · Health Care
Catalio Capital Management, LP reported holding 315,247 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$20.6M, representing 3.85% of its reported portfolio and ranking #7 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's ARWR position evolved
Catalio Capital Management, LP first disclosed a stake in ARWR in Q3 2026 at 315,247 shares (US$20.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 315.25K | $20.63M | New |
About ARWR and 13F data
ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 38 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$720.0M), Vestal Point Capital, LP (US$315.1M), FRED ALGER MANAGEMENT, LLC (US$213.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARWR
- Avoro Capital Advisors LLC 11.00M sh · $719.95M · Q3 2026
- Vestal Point Capital, LP 4.82M sh · $315.14M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 3.26M sh · $213.09M · Q3 2026
- Siren, L.L.C. 2.29M sh · $149.91M · Q3 2026
- BAKER BROS. ADVISORS LP 1.71M sh · $111.86M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 843.06K sh · $55.18M · Q3 2026
- Western Financial Corp/CA 820.24K sh · $53.68M · Q3 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held ARWR?
Catalio Capital Management, LP has disclosed ARWR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Catalio Capital Management, LP's current position in ARWR?
As of Q3 2026, Catalio Capital Management, LP holds 315.25K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $20.63M, representing 3.85% of its reported portfolio and ranking #7.
Has Catalio Capital Management, LP been buying or selling ARWR?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in ARWR.
Which other funds hold ARWR?
Other major institutional holders of ARWR include Avoro Capital Advisors LLC, Vestal Point Capital, LP, FRED ALGER MANAGEMENT, LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.